摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氨基-4,6-二氯吡啶 | 116632-24-7

中文名称
2-氨基-4,6-二氯吡啶
中文别名
4,6-二氯-2-氨基吡啶;2-胺基-4,6-二氯吡啶
英文名称
2-amino-4,6-dichloropyridine
英文别名
4,6-dichloropyridin-2-amine;4,6-dichloro-pyridin-2-ylamine
2-氨基-4,6-二氯吡啶化学式
CAS
116632-24-7
化学式
C5H4Cl2N2
mdl
MFCD04037218
分子量
163.006
InChiKey
AGJMDETXSYICGZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    112.5 °C
  • 沸点:
    287.9±35.0 °C(Predicted)
  • 密度:
    1.497±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    38.9
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    Xn
  • 安全说明:
    S26
  • 危险类别码:
    R36,R22
  • 海关编码:
    2933399090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    | 室温 |

SDS

SDS:d93f9bb9f97938b83d5e1389d478a62d
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Amino-4,6-dichloropyridine
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
H319: Causes serious eye irritation
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

Section 3. Composition/information on ingredients.
Ingredient name: 2-Amino-4,6-dichloropyridine
CAS number: 116632-24-7

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
Eye contact:
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C5H4Cl2N2
Molecular weight: 163.0

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途 2-基-4,6-二氯吡啶是一种有用的 research 化学品。其化学性质为白色结晶。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Graf, Journal fur praktische Chemie (Leipzig 1954), 1932, vol. <2> 133, p. 36,49
    摘要:
    DOI:
  • 作为产物:
    描述:
    4,6-二氯吡啶-2-氨基甲酸叔丁酯乙腈 为溶剂, 300.0 ℃ 、10.0 MPa 条件下, 以95%的产率得到2-氨基-4,6-二氯吡啶
    参考文献:
    名称:
    流动中的高温Boc脱保护及其在多步反应序列中的应用
    摘要:
    描述了使用高温流动反应器的简化的Boc脱保护。该系统使用乙腈作为溶剂,无需使用酸性条件或进行额外的后处理即可在数分钟内定性获得各种脱保护底物。还展示了流中高效的多步反应序列,其中步骤之间无需萃取或分离。
    DOI:
    10.1021/acs.orglett.6b00378
点击查看最新优质反应信息

文献信息

  • 8-Azabicyclo[3.2.1]octane derivatives
    申请人:Napier Elizabeth Susan
    公开号:US20070185156A1
    公开(公告)日:2007-08-09
    The present invention relates to a 8-azabicyclo[3.2.1]octane derivative of Formula I, wherein each of the substituents is given the definition as set forth in the specification and claims, or a pharmaceutically acceptable salt thereof or solvate thereof. The present invention also relates to a pharmaceutical composition comprising an 8-azabicyclo[3.2.1]octane derivative in admixture with one or more pharmaceutically acceptable auxiliaries and to the use of the 8-azabicyclo[3.2.1]octane derivative in therapy.
    本发明涉及一种式I的8-氮杂双环[3.2.1]辛烷生物,其中每个取代基的定义如规范和声明中所述,或其药学上可接受的盐或溶剂。本发明还涉及一种药物组合物,其包括8-氮杂双环[3.2.1]辛烷生物与一种或多种药学上可接受的辅助剂混合,并且涉及在治疗中使用8-氮杂双环[3.2.1]辛烷生物
  • [EN] 6 - ALKYNYL PYRIDINES AS SMAC MIMETICS<br/>[FR] 6-ALCYNYLE PYRIDINES UTILISÉES COMME MIMÉTIQUES DE SMAC
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2013127729A1
    公开(公告)日:2013-09-06
    This invention relates to 6-alkynyl-pyridines of general formula (I) their use as SMAC mimetics, pharmaceutical compositions containing them, and their use as a medicaments for the treatment and/or prevention of diseases characterized by excessive or abnormal cell proliferation and associated conditions such as cancer. The groups R1 to R5 have the meanings given in the claims and in the specification.
    这项发明涉及一般式(I)的6-炔基吡啶,它们作为SMAC模拟物的用途,含有它们的药物组合物,以及它们作为治疗和/或预防由细胞过度或异常增殖引起的疾病及相关症状(如癌症)的药物的用途。基团R1到R5的含义如索赔和说明书中所述。
  • 5-Alkynyl Pyridine
    申请人:REISER Ulrich
    公开号:US20130225567A1
    公开(公告)日:2013-08-29
    5-alkynyl-pyridine of general formula (I) their use as SMAC mimetics, pharmaceutical compositions containing them, and their use as a medicaments for the treatment and/or prevention of diseases characterized by excessive or abnormal cell proliferation and associated conditions such as cancer. The groups R 1 to R 5 have the meanings given in the claims and in the specification.
    通用式(I)的5-炔基吡啶 它们作为SMAC模拟物的用途,含有它们的药物组合物,以及它们作为治疗和/或预防由细胞过度或异常增殖引起的疾病及相关症状(如癌症)的药物的用途。 R组 1 至R组 5 的含义如索赔和说明书中所述。
  • ANTIBACTERIAL COMPOUNDS
    申请人:PALMER James T.
    公开号:US20120088750A1
    公开(公告)日:2012-04-12
    The present invention provides a compound of the following formula and salts thereof: Also provided is the use of these compounds as antibacterials, compositions comprising them and processes for their manufacture.
    本发明提供了一种具有以下公式和其盐类的化合物: 还提供了这些化合物作为抗生素的使用,包括它们的组合物以及它们的制造工艺。
  • General Method for the Preparation of Electron-Deficient Imidazo[1,2-<i>a</i>]pyridines and Related Heterocycles
    作者:Ivar M. McDonald、Kevin M. Peese
    DOI:10.1021/acs.orglett.5b02966
    日期:2015.12.18
    A new annulation method for the preparation of the imidazo[1,2-a]pyridine ring system under mild conditions is presented. Treatment of a 2-aminopyridine with a dimethylketal tosylate in acetonitrile at elevated temperature (80–140 °C) in the presence of catalytic Sc(OTf)3 provides the imidazo[1,2-a]pyridine product in good yield. The annulation method is broadly applicable to electron-poor 2-aminopyridines
    提出了一种在温和条件下制备咪唑并[1,2- a ]吡啶环体系的新方法。在催化的Sc(OTf)3存在下,在高温(80–140°C)下,在乙腈中用甲苯磺酸二甲基缩酮酯处理2-氨基吡啶,可得到高产率的咪唑并[1,2- a ]吡啶产物。该成环方法广泛适用于电子贫乏的2-氨基吡啶,并通过代酮与富电子和中性底物的反应,与经典的咪唑并[1,2- a ]吡啶环体系制备显示出互补性。讨论了过程的范围和机械方面的考虑。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-